INGRAM DOUGLAS S 4
4 · Sarepta Therapeutics, Inc. · Filed Jun 28, 2021
Insider Transaction Report
Form 4
INGRAM DOUGLAS S
DirectorPresident & CEO
Transactions
- Tax Payment
Common Stock
2021-06-26$80.40/sh−17,812$1,432,085→ 340,056 total
Footnotes (1)
- [F1]Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017.